Lorraine Warrington

1.4k total citations · 2 hit papers
16 papers, 759 citations indexed

About

Lorraine Warrington is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lorraine Warrington has authored 16 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Economics and Econometrics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lorraine Warrington's work include Cancer survivorship and care (12 papers), Economic and Financial Impacts of Cancer (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Lorraine Warrington is often cited by papers focused on Cancer survivorship and care (12 papers), Economic and Financial Impacts of Cancer (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Lorraine Warrington collaborates with scholars based in United Kingdom, Australia and Belgium. Lorraine Warrington's co-authors include Galina Velikova, Kate Absolom, Mark Conner, Patricia Holch, Carolyn Morris, Ian Kellar, Michael Ayres, Francesco Perrone, Puma Sundaresan and Doris Howell and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Lorraine Warrington

13 papers receiving 749 citations

Hit Papers

The role of patient-reported outcome measures in the cont... 2021 2026 2022 2024 2022 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
    2022 227 citations Massimo Di Maïo, Ethan Basch et al. Annals of Oncology profile →
  2. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
    2021 152 citations Kate Absolom, Lorraine Warrington et al. Journal of Clinical Oncology profile →

Peers

Lorraine Warrington
Anne-Lise Septans France
Elena Springall Canada
E. Green Canada
Lesley Moody Canada
Cleo A. Samuel United States
David Debono United States
Kathi Apostolidis Belgium
John Speakman United Kingdom
Lillie D. Shockney United States
Nynikka R. Palmer United States
Anne-Lise Septans France
Lorraine Warrington
Citations per year, relative to Lorraine Warrington Lorraine Warrington (= 1×) peers Anne-Lise Septans

Countries citing papers authored by Lorraine Warrington

Since Specialization
Citations

This map shows the geographic impact of Lorraine Warrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Warrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Warrington more than expected).

Fields of papers citing papers by Lorraine Warrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Warrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Warrington. The network helps show where Lorraine Warrington may publish in the future.

Co-authorship network of co-authors of Lorraine Warrington

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Warrington. A scholar is included among the top collaborators of Lorraine Warrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Warrington. Lorraine Warrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dimitrova, Vania, et al.. (2025). Using artificial intelligence to predict patient outcomes from patient-reported outcome measures: a scoping review. Health and Quality of Life Outcomes. 23(1). 37–37. 1 indexed citations
2.
Dimitrova, Vania, et al.. (2024). Using Machine Learning to Predict Unplanned Hospital Utilization and Chemotherapy Management From Patient-Reported Outcome Measures. JCO Clinical Cancer Informatics. 8(8). e2300264–e2300264. 3 indexed citations
3.
Dawkins, Bryony, Kate Absolom, Jenny Hewison, et al.. (2024). Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy. JCO Oncology Practice. 20(4). 581–590.
4.
Warrington, Lorraine, Kate Absolom, Paul D. Baxter, et al.. (2024). Quality of life, healthcare usage and finances of UK cancer survivors five years post-diagnosis: a matched controlled study. Journal of Cancer Survivorship.
5.
6.
Maïo, Massimo Di, Ethan Basch, Fabrice Denis, et al.. (2022). The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Annals of Oncology. 33(9). 878–892. 227 indexed citations breakdown →
7.
8.
Absolom, Kate, Lorraine Warrington, Jenny Hewison, et al.. (2021). Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Journal of Clinical Oncology. 39(7). 734–747. 152 indexed citations breakdown →
9.
Velikova, Galina, Kate Absolom, Lorraine Warrington, et al.. (2020). Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)—An eHealth intervention during chemotherapy.. Journal of Clinical Oncology. 38(15_suppl). 7002–7002. 4 indexed citations
10.
Warrington, Lorraine, Kate Absolom, Patricia Holch, et al.. (2019). Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting. BMJ Open. 9(1). e025185–e025185. 27 indexed citations
11.
Warrington, Lorraine, Kate Absolom, Mark Conner, et al.. (2018). Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review. Journal of Medical Internet Research. 21(1). e10875–e10875. 124 indexed citations
12.
Absolom, Kate, Patricia Holch, Lorraine Warrington, et al.. (2017). Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment. BMC Cancer. 17(1). 318–318. 42 indexed citations
13.
Holch, Patricia, Lorraine Warrington, Ada Keding, et al.. (2017). Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Annals of Oncology. 28(9). 2305–2311. 80 indexed citations
14.
Warrington, Lorraine, et al.. (2016). An audit of acute oncology services: patient experiences of admission procedures and staff utilisation of a new telephone triage system. Supportive Care in Cancer. 24(12). 5041–5048. 23 indexed citations
15.
16.
Warrington, Lorraine, Kate Absolom, & Galina Velikova. (2015). Integrated care pathways for cancer survivors – a role for patient-reported outcome measures and health informatics. Acta Oncologica. 54(5). 600–608. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne-Lise Septans Breakdown of academic impact, for papers by Elena Springall Breakdown of academic impact, for papers by E. Green Breakdown of academic impact, for papers by Lesley Moody Breakdown of academic impact, for papers by Cleo A. Samuel Breakdown of academic impact, for papers by David Debono Breakdown of academic impact, for papers by Kathi Apostolidis Breakdown of academic impact, for papers by John Speakman Breakdown of academic impact, for papers by Lillie D. Shockney Breakdown of academic impact, for papers by Nynikka R. Palmer
Rankless by CCL
2026